Is Sanmina Corp. overvalued or undervalued?

As of 28 April 2025, the valuation grade for Sanmina Corp. has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued. Key ratios include a P/E ratio of 32, an EV to EBITDA of 17.00, and a ROCE of 19.30%. In comparison, Masimo Corp. has a significantly higher P/E ratio of 378.77, while Globus Medical, Inc. stands at 34.78, suggesting that Sanmina Corp. offers a more favorable valuation relative to its peers.
The recent performance of Sanmina Corp. has outpaced the S&P 500, with a year-to-date return of 21.20% compared to the index's 2.44%. This strong performance, combined with its attractive valuation metrics, reinforces the conclusion that Sanmina Corp. is undervalued in the current market environment.